<h4>Objective</h4>Through the Australian and New Zealand Haemostasis Registry, we report on the Australian and New Zealand experience with recombinant activated factor VII (rFVIIa) in obstetric patients.<h4>Methods</h4>The role of rFVIIa for off-label indications, including trauma, cardiac surgery, ...
No comments yet
Be the first to share your thoughts!